Literature DB >> 12099914

Multiple sclerosis complexity in selected populations: the challenge of Sardinia, insular Italy.

S Sotgiu1, M Pugliatti, A Sanna, A Sotgiu, P Castiglia, G Solinas, A Dolei, C Serra, B Bonetti, G Rosati.   

Abstract

Several lines of evidence indicate a genetic contribution to multiple sclerosis (MS) both in terms of predisposition to the disease and of immunological mechanisms which are known to play crucial roles in MS pathogenesis. The presence of high- and low-risk areas for MS in neighbouring regions supports the theory that MS predisposition is influenced by a complex interaction of genetic and environmental factors. Therefore, the use of genetically homogeneous and geographically isolated populations becomes an increasing requirement to reduce biasing biological variables. Sardinians fulfil these conditions well because of their different phylogeny from Europeans and the unique selective pressures which shaped their genome. Sardinians display amongst the highest MS prevalence rates world-wide and increasing MS incidence rates over time. Also, MS in Sardinia is linked to distinct human leucocyte antigen (HLA) alleles and associated to different patterns of cytokine production from lymphoid cells of different HLA subtypes. In this context, recent findings and future perspectives on the peculiarities of Sardinian MS concerning genetic, immunological and epidemiological aspects are presented. So far, our results indicate that variations at the level of territorial distribution and HLA-association are present which render MS heterogeneous even in this ethnically homogeneous population.

Entities:  

Mesh:

Year:  2002        PMID: 12099914     DOI: 10.1046/j.1468-1331.2002.00412.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  8 in total

1.  Cytoskeletal proteins in the cerebrospinal fluid as biomarker of multiple sclerosis.

Authors:  Roberto Madeddu; Cristiano Farace; Paola Tolu; Giuliana Solinas; Yolande Asara; Maria Alessandra Sotgiu; Lucia Gemma Delogu; Jose Carlos Prados; Stefano Sotgiu; Andrea Montella
Journal:  Neurol Sci       Date:  2012-02-24       Impact factor: 3.307

2.  Distinctive HLA-II association with primary biliary cholangitis on the Island of Sardinia.

Authors:  Maria Grazia Clemente; Fulvia Frau; Matilde Bernasconi; Maria Doloretta Macis; Lucia Cicotto; Giampaolo Pilleri; Stefano De Virgiliis; Paolo Castiglia; Patrizia Farci
Journal:  United European Gastroenterol J       Date:  2016-08-09       Impact factor: 4.623

3.  Seasonal fluctuation of multiple sclerosis births in Sardinia.

Authors:  Stefano Sotgiu; M Pugliatti; Maria A Sotgiu; Maria L Fois; Giannina Arru; Alessandra Sanna; Giulio Rosati
Journal:  J Neurol       Date:  2005-07-20       Impact factor: 6.682

Review 4.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

Review 5.  The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis.

Authors:  Elena Morandi; Radu Tanasescu; Rachael E Tarlinton; Cris S Constantinescu; Weiya Zhang; Christopher Tench; Bruno Gran
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

Review 6.  Infectious causes of multiple sclerosis.

Authors:  Donald H Gilden
Journal:  Lancet Neurol       Date:  2005-03       Impact factor: 44.182

7.  The role of Bordetella pertussis in the development of multiple sclerosis.

Authors:  Mohammad Mahdi Majzoobi; Mohammad Reza Macvandi; Hamidreza Ghasemi Basir; Zahra Sanaei; Shahir Mazaheri; Maryam Afza; Mohammad Reza Arabestani
Journal:  BMC Neurol       Date:  2022-03-01       Impact factor: 2.474

Review 8.  Human Endogenous Retrovirus as Therapeutic Targets in Neurologic Disease.

Authors:  Karen Giménez-Orenga; Elisa Oltra
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.